Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk

Cancer Research

Volumn 72, Issue 9, 2012, Pages 2304-2313

  Brennan, Kevin ^a   Garcia Closas, Montserrat ^b   Orr, Nick ^b   Fletcher, Olivia ^b   Jones, Michael ^b   Ashworth, Alan ^b   Swerdlow, Anthony ^b   Thorne, Heather ^c   Riboli, Elio ^a   Vineis, Paolo ^a,d   Dorronsoro, Miren ^e   Clavel Chapelon, Francoise ^f   Panico, Salvatore ^g   Onland Moret, N Charlotte ^h   Trichopoulos, Dimitrios ^i,j   Kaaks, Rudolf ^k   Khaw, Kay Tee ^l   Brown, Robert ^a,b   Flanagan, James M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d HuGeF Foundation   (Italy)

^e BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^f CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^j HELLENIC HEALTH FOUNDATION   (Greece)

^k GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^l UNIVERSITY OF CAMBRIDGE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADULT; AGE; AGED; ARTICLE; ATM GENE; BLOOD SAMPLING; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA METHYLATION; FEMALE; GENE; GENE LOCUS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PYROSEQUENCING; QUANTITATIVE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; DNA METHYLATION; DNA, NEOPLASM; DNA-BINDING PROTEINS; EUROPE; FEMALE; GREAT BRITAIN; HUMANS; LEUKOCYTES; MIDDLE AGED; NEW ZEALAND; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 84860516671     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-3157     Document Type: Article

References (44)

1. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007;128: 683-92. (Pubitemid 46273572)
2. Bjornsson HT, Fallin MD, Feinberg AP. An integrated epigenetic and genetic approach to common human disease. Trends Genet 2004;20: 350-8. (Pubitemid 38943025)
3. Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Weisenberger DJ, Shen H, et al. Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res 2010;20:440-6.
4. Rakyan VK, Down TA, Maslau S, Andrew T, Yang TP, Beyan H, et al. Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. Genome Res 2010;20:434-9.
5. Li S, Hursting SD, Davis BJ, McLachlan JA, Barrett JC. Environmental exposure,DNAmethylation, and gene regulation: lessons from diethylstilbesterol- induced cancers. Ann N Y Acad Sci 2003;983:161-9. (Pubitemid 36399329)
6. Kovalchuk O, Burke P, Besplug J, Slovack M, Filkowski J, Pogribny I. Methylation changes in muscle and liver tissues of male and female mice exposed to acute and chronic low-dose X-ray-irradiation. Mutat Res 2004;548:75-84. (Pubitemid 38446883)
7. Ma S, Liu X, Jiao B, Yang Y, Liu X. Low-dose radiation-induced responses: focusing on epigenetic regulation. Int J Radiat Biol 2010;86:517-28.
8. Christensen BC, Kelsey KT, Zheng S, Houseman EA, Marsit CJ, Wrensch MR, et al. Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake. PLoS Genet 2010;6:e1001043.
9. Vineis P, Chuang SC, Vaissiere T, Cuenin C, Ricceri F, Johansson M, et al.DNAmethylation changes associated with cancer risk factors and blood levels of vitamin metabolites in a prospective study. Epigenetics 2011;6:195-201.
10. Breitling LP, Yang R, Korn B, Burwinkel B, Brenner H. Tobacco-smoking- related differential DNA methylation: 27K discovery and replication. Am J Hum Genet 2011;88:450-7.
11. Baccarelli A, Wright RO, Bollati V, Tarantini L, Litonjua AA, Suh HH, et al. Rapid DNA methylation changes after exposure to traffic particles. Am J Respir Crit Care Med 2009;179:572-8.
12. Meaburn EL, Schalkwyk LC, Mill J. Allele-specific methylation in the human genome: implications for genetic studies of complex disease. Epigenetics 2010;5:578-82.
13. Feinberg AP, Irizarry RA, Fradin D, Aryee MJ, Murakami P, Aspelund T, et al. Personalized epigenomic signatures that are stable over time and covary with body mass index. Sci Transl Med 2010;2:49ra67.
14. Flanagan JM, Munoz-Alegre M, Henderson S, Tang T, Sun P, Johnson N, et al. Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients. Hum Mol Genet 2009;18:1332-42.
15. Marsit CJ, Koestler DC, Christensen BC, Karagas MR, Houseman EA, Kelsey KT. DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer. J Clin Oncol 2011;29:1133-9.
16. Moore LE, Pfeiffer RM, Poscablo C, Real FX, Kogevinas M, Silverman D, et al. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol 2008;9:359-66.
17. Cash HL, Tao L, Yuan JM, Marsit CJ, Houseman EA, Xiang YB, et al. LINE-1 hypomethylation is associated with bladder cancer risk among nonsmoking Chinese. Int J Cancer 2012;130:1151-9.
18. Wilhelm CS, Kelsey KT, Butler R, Plaza S, Gagne L, Zens MS, et al. Implications of LINE1 methylation for bladder cancer risk in women. Clin Cancer Res 2010;16:1682-9.
19. Hsiung DT, Marsit CJ, Houseman EA, Eddy K, Furniss CS, McClean MD, et al. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2007;16:108-14. (Pubitemid 46174272)
20. Cho YH, Yazici H, Wu HC, Terry MB, Gonzalez K, Qu M, et al. Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients. Anticancer Res 2010;30:2489-96.
21. Cui H, Onyango P, Brandenburg S,WuY, Hsieh CL, Feinberg AP. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res 2002;62:6442-6. (Pubitemid 35364103)
22. Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S, et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 2003;299:1753-5. (Pubitemid 36337205)
23. Cruz-Correa M, Cui H, Giardiello FM, Powe NR, Hylind L, Robinson A, et al. Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition. Gastroenterology 2004;126:964-70. (Pubitemid 38451167)
24. Jirtle RL. IGF2 loss of imprinting: a potential heritable risk factor for colorectal cancer. Gastroenterology 2004;126:1190-3. (Pubitemid 38451189)
25. Ito Y, Koessler T, Ibrahim AE, Rai S, Vowler SL, Abu-Amero S, et al. Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer. Hum Mol Genet 2008;17:2633-43.
26. Widschwendter M, Apostolidou S, Raum E, Rothenbacher D, Fiegl H, Menon U, et al. Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study. PLoS One 2008;3: e2656.
27. Iwamoto T, Yamamoto N, Taguchi T, Tamaki Y, Noguchi S. BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation. Breast Cancer Res Treat 2011;129:69-77.
28. Snell C, Krypuy M, Wong EM, Loughrey MB, Dobrovic A. BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype. Breast Cancer Res 2008;10:R12.
29. Wong EM, Southey MC, Fox SB, Brown MA, Dowty JG, Jenkins MA, et al. Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer. Cancer Prev Res (Phila) 2010;4: 23-33.
30. Wang X, Zhu H, Snieder H, Su S, Munn D, Harshfield G, et al. Obesity related methylation changes in DNA of peripheral blood leukocytes. BMC Med 2010;8:87.
31. Pedersen KS, Bamlet WR, Oberg AL, de Andrade M, Matsumoto ME, Tang H, et al. Leukocyte DNA methylation signature differentiates pancreatic cancer patients from healthy controls. PLoS One 2011;6: e18223.
32. Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Gayther SA, Apostolidou S, et al. An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS One 2009;4:e8274.
33. Feinberg AP. The epigenetics of cancer etiology. Semin Cancer Biol 2004;14:427-32. (Pubitemid 39360990)
34. Irizarry RA, Ladd-Acosta C,WenB,WuZ, Montano C, Onyango P, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009;41:178-86.
35. Mann GJ, Thorne H, Balleine RL, Butow PN, Clarke CL, Edkins E, et al. Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 2006;8:R12.
36. Swerdlow AJ, Jones ME, Schoemaker MJ, Hemming J, Thomas D, Williamson J, et al. The Breakthrough Generations Study: design of a long-term UK cohort study to investigate breast cancer aetiology. Br J Cancer 2011;105:911-7.
37. Riboli E, Kaaks R. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997;26 Suppl 1:S6-14.
38. Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw 2010;36:1-48.
39. Choi JY, James SR, Link PA, McCann SE, Hong CC, Davis W, et al. Association between global DNA hypomethylation in leukocytes and risk of breast cancer. Carcinogenesis 2009;30:1889-97.
40. Flanagan JM, Cocciardi S, Waddell N, Johnstone CN, Marsh A, Henderson S, et al. DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status. Am J Hum Genet 2010;86:420-33.
41. Wu HC, John EM, Ferris JS, Keegan TH, Chung WK, Andrulis I, et al. Global DNA methylation levels in girls with and without a family history of breast cancer. Epigenetics 2011;6:29-33.
42. Shenker N, Flanagan JM. Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research. Br J Cancer 2012;106:248-53.
43. Labreche HG, Nevins JR, Huang ES. Integrating factor analysis and a transgenic mouse model to reveal a peripheral blood predictor of breast tumors. BMC Med Genomics 2011;4:61.
44. Rakyan VK, Down TA, Balding DJ, Beck S. Epigenome-wide association studies for common human diseases. Nat Rev Genet 2011;12: 529-41.